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Metabolic ﬂux analysis is a vital tool used to determine the ultimate output of cellular metabolism and thus detect
biotechnologically relevant bottlenecks in productivity. 13C-based metabolic ﬂux analysis (13C-MFA) and ﬂux balance analysis
(FBA) have many potential applications in biotechnology. However, noteworthy hurdles in ﬂuxomics study are still present. First,
several technical diﬃculties in both 13C-MFA and FBA severely limit the scope of ﬂuxomics ﬁndings and the applicability of
obtained metabolic information. Second, the complexity of metabolic regulation poses a great challenge for precise prediction and
analysis of metabolic networks, as there are gaps between ﬂuxomics results and other omics studies. Third, despite identiﬁed
metabolic bottlenecks or sources of host stress from product synthesis, it remains diﬃcult to overcome inherent metabolic
robustness or to eﬃciently import and express nonnative pathways. Fourth, product yields often decrease as the number of
enzymatic steps increases. Such decrease in yield may not be caused by rate-limiting enzymes, but rather is accumulated
through each enzymatic reaction. Fifth, a high-throughput ﬂuxomics tool hasnot been developed for characterizing nonmodel
microorganisms and maximizing their application in industrial biotechnology. Reﬁning ﬂuxomics tools and understanding these
obstacles will improve our ability to engineer highlyeﬃcient metabolic pathways in microbial hosts.
1.Introduction
Numerous chemical compounds, ranging from the
antimalaria drug artemisinin [1] to the “biofuel” butanol
[2, 3], have been produced with the aid of synthetic
biology tools. The ability to eﬃciently synthesize natural or
unnatural products requires a systems-level understanding
of metabolism. Functional genomics tools such as genome
sequencing, proﬁling of mRNA transcripts, and proteomics,
are widely used to attain a comprehensive knowledge of how
metabolic components (genes, proteins and metabolites) are
regulated. In contrast to traditional omics tools, ﬂux analysis
(measurement of metabolite turnover rates) has become
instrumental for physiological prediction and enzymatic rate
quantiﬁcation in metabolic networks [4]. This technology
also allows for the identiﬁcation of metabolic interactions
and the knowledge-based design of cellular functions. As
such, one can utilize this tool to rationally modify biological
hosts and analyze global physiological changes resulting
from genetic modiﬁcations.
Fluxomics, the cell-wide quantiﬁcation of intracellular
metabolite turnover rates, was ﬁrst performed via ﬂux
balance analysis (FBA). This method uses the stoichiometry
of the metabolic reactions in addition to a series of physical,
chemical and biological characteristics (thermodynamics,
energybalance,generegulation,etc.)toconstrainthefeasible
ﬂuxes under a given objective function (e.g., maximal
biomass production). FBA is an underdetermined model
(the number of constraints is smaller than the number
of reactions in the metabolic network), which may give
unrealistic metabolic readout. In spite of this limitation, FBA
provides a useful framework for predicting a wide variety
of cellular metabolisms. A complementary approach, 13C-
based metabolic ﬂux analysis (13C-MFA) allows for precise
determinationsofmetabolicstatusunderaparticulargrowth
condition. The key to 13C-MFA is isotopic labeling, whereby2 Journal of Biomedicine and Biotechnology
microbes are cultured using a carbon source with a known
distribution of 13C. By tracing the transition path of the
labeled atoms between metabolites in the biochemical net-
work, one can quantitatively determine intracellular ﬂuxes.
Flux analysis can not only provide genetic engineers with
strategies for “rationally optimizing” a biological system,
but also reveal novel enzymes useful for biotechnology
applications [4]. However, ﬂux analysis platforms are still
not routinely established in biotechnology companies. This
review paper addresses current developments and challenges
in the ﬁeld of ﬂuxomics, which may guide future study
to bridge the gap between systems analysis of cellular
metabolism and application in biotechnology.
2.Advances andLimitationsinMetabolic
FluxAnalysis
2.1. Steady-State Flux Model. FBA and 13C-MFA concentrate
on the stoichiometric (rather than kinetic) properties of
metabolic networks. FBA has been widely applied to predict
cell growth rate, product yield using diﬀerent feedstocks,
lethality of gene knockouts, and advantageous pathway
modiﬁcations [5]. Such a model provides general guidelines
for metabolic engineering and thus is a viable ﬁrst step
towards improving biosynthetic yield [6]. The hallmark of
large scale FBA is the constraint-based reconstruction and
analysis toolbox (COBRA) [7], which provides a general
platform for ﬂuxomics studies.
A number of optimization algorithms and computa-
tional strategies for resolving in silico and in vivo inconsis-
tencies have been proposed to improve the applicability of
FBA [6, 8]. For example, incorporation of thermodynamic
principles into FBA can constrain solution space (i.e.,
energy balance analysis) and obtain both stoichiometrically
and thermodynamically feasible ﬂuxes [9]. To describe the
“nonoptimal” metabolic behaviors, FBA can use a bilevel
optimization approach to estimate the potential trade-oﬀ
between biomass accumulation and the yield of a desired
product [10]. FBA can also relax the objective function for
maximization of the biomass and apply a Minimization of
Metabolic Adjustment Algorithm to solve ﬂuxes in mutant
strains [9]. Such an algorithm calculates ﬂuxes by minimiz-
ing the diﬀerence between the wild-type ﬂux distributions
and the knockout-strain ﬂuxes. Furthermore, FBA can be
integrated with metabolic pathway analysis (MPA). MPA is
a qualitative technique that examines functional routes exist-
ing in a metabolic network without requiring knowledge of
reaction rates [11]. Combining MPA with FBA can quantita-
tively trace the plausible paths for optimal product synthesis,
calculate cellular metabolism, and predict phenotypes under
genetic manipulations or culture conditions [12]. One main
advantage of FBA is its capability for genome-scale modeling
(including thousands of reactions), which bridge genomic
annotation and functional metabolic output. Accordingly,
the number of FBA models has increased exponentially since
1999 [13].
13C-MFA aims to rigorously quantify pathway activities
in intracellular metabolism by using both the isotopic
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Figure 1: An iterative approach of ﬂuxomic analysis and rational
metabolic engineering.
labeling approach and in silico computation. 13C-MFA is
accomplished by feeding microbes a 13C-labeled carbon
source, measuring the enrichment pattern of the isotopomer
in metabolites (e.g., amino acids), and deciphering the
ﬂuxes via computational routines [14]. Since carbon ﬂuxes
through a metabolic network generate unique labeling
patterns in metabolites, the overall ﬂux distributions can be
determined using isotopomer information. Advances in 13C-
MFA,includingmassspectrometry-basedmetabolomicsand
isotopomer modeling approaches (such as novel algorithm
using elementary metabolite units), have been discussed in
recent papers [4, 15, 16].
Furthermore, open-source software has recently been
published that facilitates in silico modelling. For example,
WEbcoli is web-based software for ﬂux balance analysis
of E.coli [17]. In addition, OpenFLUX is computationally
eﬃcient software for 13C-MFA [15], which incorporates the
elementary metabolite unit (EMU) framework for calcula-
tionofisotopomerbalances[18].User-friendlysoftwaresuch
as this allows biologists to perform ﬂuxomics studies with
little programming knowledge.
Methodologies for FBA and 13C-MFA share two key
characteristics: the use of a metabolic network and the
assumption of a steady metabolic state (for internal metabo-
lites). However, the two techniques have diﬀerent purposes.
FBA proﬁles the “optimal” metabolism for the desired
performance; 13C-MFA measures in vivo operation of a
metabolic network. The two approaches to ﬂux analysis
are complementary when developing a rational metabolic
engineering strategy. By comparing existent metabolic ﬂuxes
which were empirically determined via 13C-MFA to the opti-
mal metabolisms predicted by both FBA and other “omics”
tools (such as transcription analysis), one can deduce gene
targets for solving biotechnologically relevant productivity
bottlenecks [19]. Figure 1 shows that iterative ﬂux analysis
and genetic engineering of microbial hosts can remove
competitive pathways or toxic byproducts, amplify genes
encoding key metabolites, and balance energy metabolism
[6].
2.2. Metabolic Control and Dynamic Flux Analysis. FBA
and 13C-MFA disregard dynamic intracellular behavior. ThisJournal of Biomedicine and Biotechnology 3
avoids the diﬃculties in developing kinetic models and per-
forming intracellular experimental measurements. However,
many biological systems may not maintain a meaningful
metabolic (or isotopic) steady state during the fermentation
process [20–22]. The description of metabolic perturbation
and regulatory mechanisms requires kinetic modeling and
control theories. For example, metabolic control analysis
(MCA) couples local enzyme kinetics with systematic behav-
ior to predict the control exerted on the targeted pathways
by diﬀerent components (e.g., transcription, enzymes) [23].
Although MCA is not a quantitative measurement of ﬂux,
MCA can pinpoint bottle-neck enzymes (enzymes having
the largest eﬀect on the desired ﬂux) in a pathway and
allow the analysis of steady-state metabolism in response
to changes in the cellular environment [24]. In addition to
MCA, the cybernetic approach (a model based on process
dynamics and control) has been introduced for study of
multienzyme systems and metabolic regulation [25]. By
incorporating both the enzyme kinetics in pathways and
the enzyme synthesis kinetics, the cybernetic approach
emphasizes microbial process dynamics and control during
complicated fermentations [26].
Both MCA and the cybernetics approach focus on a
simpliﬁed pathway network. To perform cell-wide quan-
titative analysis of a dynamic system, it is necessary to
integrate the kinetic modeling with FBA and 13C-MFA.
Dynamic FBA (dFBA) has been developed to illuminate
changing global enzyme activities [27, 28]. To avoid ordi-
nary diﬀerential equations and dynamic optimization for
describing intracellular metabolism, dFBA can use the Static
Optimization Approach (SOA) [29] which divides the time-
course into numerous small intervals. At each time interval,
a steady-state ﬂux is calculated under the assumption of fast
intracellular dynamics. By combining stoichiometric FBA
for intracellular metabolism with dynamic mass balances
on extracellular substrates and products, it is possible
to reconstruct dFBA model for genome-scale analysis of
microbial metabolisms in industrial fermentations, where
product synthesis is often under dynamic control [30, 31].
Recently, 13C-dMFA (dynamic metabolic ﬂux analysis)
has been developed for isotopically nonstationary cultures.
To proﬁle the ﬂux distributions for fed-batch cultures
(slow dynamic metabolism), isotopic pseudosteady state
was assumed and two dilution parameters were introduced
to account for isotopic transients [92]. Another approach
(Kinetic Flux Proﬁling) for solving intracellular ﬂuxes is to
createa suddenincreaseofthe portion of 13Cin thesubstrate
feed, then measure time-course samples as 13Cm o v e sf r o m
the substrate into the metabolites [33]. The ﬂuxes can
be calculated based on the rates of isotopic enrichment
multiplied by the intracellular metabolite concentrations. A
similar principle has been proposed for the ﬂux analysis
of photoautotrophic microorganisms [34]a n dE. coli in
an isotopic transient phase [35]. If the culture is under
both metabolic and isotopic nonstationary state, exploratory
and sophisticated 13C-dMFA (dynamic 13C-MFA) models
have to be used to calculate both metabolic and isotopic
kinetics [20, 36, 37]. To solve the 13C-dMFA problem
eﬃciently, a set of computational algorithms have been
developed for tracing nonstationary isotopomer labeling in
response to in vivo ﬂux distributions [20, 36, 37]. The
EMU (elementary metabolite unit) framework has also been
applied in 13C-dMFA [18, 38], because such algorithm can
signiﬁcantly improve computational times for tracing the
labeling information [39]. To avoid extensive simulation of
dynamic isotopomer patterns, the SOA has to be applied
by dividing the growth period into small time intervals
(30 ∼ 60min), then the “mini” quasi-steady state 13C-MFA
can be applied at each time interval based on constraints
from simultaneous isotopomer analysis of the fast turnover
metabolites [40]. By examining ﬂux proﬁles over all time
intervals, one can resolve the metabolic transients during the
entire cultivation period.
2.3. Technical Limitations of Fluxomics. Cell-wide ﬂuxomics
tools (i.e., FBA and 13C-MFA) have technical limitations.
In genome-scale FBA models, the number of constraints
(i.e., the availability of quantitative metabolite data) is much
smaller than the number of reactions in the metabolic
network. The calculation of such underdetermined systems
depends on objective functions where one assumes that the
metabolism optimizes its native “goals” (such as biomass or
cofactor production) [41]. This optimization principle has
been questioned for several reasons. First, biological systems
(e.g., Bacillus subtilis) seem to display suboptimal growth
performance [42]. Second, a previous study examined 11
objective functions in E. coli and found no single objec-
tive function that can perfectly describe ﬂux states under
various growth conditions [43]. For example, unlimited
aerobic growth on glucose is best described by a nonlinear
maximization of the ATP yield per ﬂux unit, but nutrient-
limited continuous cultures favor biomass yield as the objec-
tive function. Third, some native cellular processes cannot
be simply described by FBA. For example, cyanobacterial
species (i.e., Cyanothece 51142) maintain their circadian
rhythms (e.g., nitrogen ﬁxation and light dependent reaction
activities) under nutrient-suﬃcient and continuous light
conditions [44, 45].
The application of 13C-MFA in industrial biotechnology
also has several bottlenecks. The most prevalent constriction
occurs because current techniques are insuﬃcient for mea-
suring large-scale metabolic networks. Obtaining labeling
information of free metabolites rather than amino acids and
solving large-scale nonlinear ﬂux models pose two key chal-
lenges. As a result, most obtained ﬂux information is limited
tocentralmetabolism.Todate,onlytwolarge-scale 13C-MFA
(>300reactions)havebeenreported,butmanyﬂuxesintheir
reports cannot be precisely determined due to insuﬃcient
constraints [46, 47]. The genome-scale 13C - M F Ai ss t i l li n
its infancy and requires further development of the relevant
experimental techniques and computational tools [48]. A
second issue is that 13C-dMFA is still poorly developed for
determining dynamic metabolic behavior. It is diﬃcult for
rapid sampling and precise measurements of metabolites at
shorttimeintervalsthroughouttheentirecultureperiod.For
example, to measure absolute intracellular metabolite con-
centrations,onehastogrowcellinfully 13C-labeledmedium,4 Journal of Biomedicine and Biotechnology
then the labeled cells are extracted with quenching solvent
containing known concentrations of unlabeled internal
standards (the concentrations of metabolites are calculated
using the isotope ratio-based approach) [49]. Such mea-
surement requires extremely high cost of analytical eﬀorts
including quick sampling, rapid metabolite extraction, and a
high-resolution LC-MS instrument. Furthermore, the time-
dependent model includes ordinary diﬀerential equations
and signiﬁcantly increases the computational complexity
[20, 35]. Third, ﬂux determination assumes that enzymatic
reactions are homogenous inside the cell and that there are
notransportlimitations betweenmetabolitepools. However,
eukaryotes have organelles (compartments) that may have
diﬀusion limitations or metabolite channeling [14, 50].
Compartmentalization of amino acid biosynthesis further
clouds the obtained amino acid-based labeling information
[51]. Therefore, conﬁdent 13C-MFA for eukaryotes not only
requires the combination of diﬀerent analytical tools (GC-
MS, LC-MS and NMR) to obtain extensive labeling informa-
tion[52],butalsoadequatesampleprocessingandextraction
methods (e.g., separation of compartments by ultracentrifu-
gation). A fourth problem is that some industrial hosts and
the great majority of environmental microbes resist culti-
vation in minimal media, and introducing other nutrient
sources often signiﬁcantly complicates metabolite labeling
measurements and ﬂux analyses [53]. Finally, a microbial
community demonstrates complex metabolic interactions
between species. To date, only a few FBA models have been
developed for community studies [54, 55]. The exchange of
metabolites among species is nearly impossible to unravel by
13C-MFA because complete separation and measurement of
metabolitesfromasinglespeciesinamicrobialcommunityis
impossible [4]. These technical limitations in both FBA and
MFA models are responsible for the gap between ﬂuxomics
and its applicability in biotechnology.
3. IntegrationofFluxomicswithOther“Omics”
It is desirable to integrate the concepts of systems biology
(which combines the readouts from transcription as well
as protein/metabolite proﬁling) with ﬂuxomics (Figure 2)
[48].Forexample, 13C-MFA,enzymeactivityassays,andRT-
PCR analysis can be used together to study E.coli mutants’
metabolism [56]. Additionally, the responses of E. coli to
genetic modiﬁcation have been systematically examined by
utilizing multiple high-throughput “omics” methods [57].
The results illuminate relatively small changes in mRNA and
proteins in response to genetic disruptions, which allow the
cell to maintain a stable metabolic state under changing
growth conditions. A similar approach to the study of Syne-
chocystis6803hasshownthattheregulationofsomeenzymes
is sensitive to light conditions [58]. Many other regulatory
mechanisms, however, still remain unknown. Furthermore,
global regulators in industrial microorganisms have been
successfully identiﬁed by correlating transcript/transduction
levels and metabolic ﬂuxes [59–62]. The discovery of func-
tioning regulators provides insight to the entire regulation in
metabolic network.
On the other hand, challenges in integrated “omics”
studies are also present. The lack of understanding of
metabolic regulation at diﬀerent metabolic levels compli-
cates the rational design of biological systems, which is
a major barrier in industrial biotechnology. For example,
posttranscriptional regulation poses a signiﬁcant challenge
in integrating ﬂuxomics with other “omics” studies. It
is well known that transcript and protein data correlate
relatively well for speciﬁc pathways, yet this correlation can
bepoorincell-wideanalyses[76].Furthermore,mostmRNA
expression studies insuﬃciently predict enzyme activities or
ﬂux changes in many E. coli pathways [77]. In studies on
the adaptation of E. coli to environmental perturbations,
the tricarboxylic acid cycle is found to correlate well with
molecular changes at the transcriptional level, but ﬂux
alterations in other central metabolic pathways seem to
be uncorrelated to changes in the transcriptional network
[78]. Because of the complexity of regulatory mechanisms
spanning multiple cellular processes, ﬂuxomics and other
“omics” studies may have inconsistent observations which
complicate systems-level analyses.
4. Fluxomics of Microbes for
IndustrialBiotechnology
FBA allows in silico simulations of metabolism in “indus-
trial workhorses,” from which desired strains or targeted
mutations can be identiﬁed. 13C-MFA can assess in vivo
metabolism of engineered strains under speciﬁc growth
conditions and validate FBA results. Here, we summarize
recentapplicationsofFBAand 13C-MFAforcommonly-used
industrial chassis (i.e., E. coli, B. subtilis and S. cerevisiae)
and for nonmodel microorganisms (i.e., less-characterized
or newly-discovered microorganisms).
4.1. Escherichia coli Model. E. coli is the most commonly
utilized species in fermentation industry. E. coli ﬂux models
were reported as early as the 1990s [79, 80]. For biotech-
nology applications, the Liao group ﬁrst applied metabolic
pathway analysis (MPA) to guide the genetic manipulation
of E.coli strains and channel the metabolic ﬂuxes from
carbohydrate to the aromatic amino acid pathway [81].
The Maranas group has integrated cell growth and product
synthesis in the OptKnock toolbox [10] and applied it to
construct high-performance mutants. The computer-aided
designs have shown improved lactic acid, succinate, and
1,3-propanediol production [82]. FBA can predict lethality
in a metabolic network where deletions of more than one
nonessential gene mutants may trigger the death of the
organism.Forexample,theMaranasgroup[83]analyzedthe
gene/reaction essentiality in a genome-scale model of E. coli
and systemically identiﬁed possible pairs of synthetic lethals:
nonessential genes whose simultaneous knockouts would
have a potentially lethal eﬀect. Incorporating information
about synthetic lethality into the new model will curb the
construction of ill-designed biological systems for biotech-
nology. Furthermore, FBA can be used to ﬁnd rate-limiting
steps for product synthesis. For example, FBA revealed geneJournal of Biomedicine and Biotechnology 5
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Figure 2: 13C-assisted cellular metabolism analysis.
targets, and modiﬁcation of those genes (i.e., knocking out
the genes for pyruvate forming enzymes, overexpression of
the glyoxylate shunt and glucose transport system) resulted
inmorethanaten-foldincreaseinsuccinateproduction[84–
86]. FBA has also been used to improve genetic strategies for
the overproduction of secondary metabolites, such as amino
acids [87] and lycopene [88].
Besides genetic strategies, FBA can provide useful infor-
mation for the design of optimal fermentation conditions.
For example, an FBA model was used to identify nutrient
limitationsduringrecombinantinterleukin-2(IL-2)produc-
tion in E. coli. By supplementing speciﬁc amino acids, IL-
2 production increased two-fold in fed-batch fermentation
[89]. Recently,a reactor-scaledFBA model was developed via
a static optimization Approach to analyze E. coli metabolism
for the production of a biopharmaceutical drug [27]. dFBA
contains a steady state FBA model embedded within a
dynamic kinetic model that describes the time evolution
of fermentation process variables (e.g., biomass growth,
glucose consumption and products synthesis). Such a model
provided guidelines for the optimization of fermentations at
the scale of a 1000L process.
The 13C - M F Am o d e lw a sﬁ r s tu s e dt oi n v e s t i g a t e
metabolic regulation in E.coli under diﬀerent genetic and
environmental conditions [90]. 13C-MFA has also been
used to examine various biotechnological processes involved
in the production of pharmaceuticals, amino acids and
polymers. A large scale 13C-MFA with over 300 reactions
was successfully developed for amorphadiene (a precursor of
the antimalaria drug) producing E. coli strains [46]. Another
studyrevealedagrowthphase-dependentmetabolicshiftina
lysine-producingE.colistrain[91].Thisworkwasperformed
in a fed-batch culture with rich medium (containing yeast
extract), and metabolic ﬂuxes in both exponential growth
and stationary phases were estimated by measuring free
metabolites. Metabolic analysis of the stationary phase is
important since many products are synthesized during a
nongrowth phase. In a third example, 13C-MFA of a 1,3-
propanediol producing E. coli strain was conducted in fed-
batch fermentation [92]. The 13C-MFA results showed a
decreasein thesplit ratio between glycolysisandthepentose-
phosphate pathway over the time-course of the culture in
response to increasing 1,3-propanediol ﬂuxes.
4.2. Bacillus subtilis Model. B. subtilis is the industrial
organism of choice for the production of vitamins, antibi-
otics, enzymes, and nucleosides. The FBA model for
B. subtilis was constructed based on a combination of
genomic, biochemical, and physiological information [93].
TheFBAmodel wasiteratively correctedandimproved using
information from high-throughput phenotypic screens of
mutants,substrateutilization,geneessentiality,andsequence
analyses. The B. subtilis ﬂux model is mostly studied for
riboﬂavinproduction,focusingonfouraspects:investigating
phenotypes of wild type and knock-out strains, assessing
production capacity, identifying the impact of diﬀerent car-
bon sources on biosynthesis, and characterizing the cellular
responsetodiﬀerentcultureconditions.TheSauergrouphas
extensively investigated riboﬂavin-producing strains. They
ﬁrst used an FBA model to quantify growth maintenance
coeﬃcients, the maximum growth yield, and the speciﬁc
riboﬂavin production rate in continuous cultivation [94].
Later on, they applied 13C-MFA to the same strain and
found that genetic manipulations should target the NADPH
balance and riboﬂavin biosynthetic pathways [95]. In other
studies on B. subtilis, they revealed several guidelines for
high-yield riboﬂavin production (1) they compared the
metabolicﬂuxdistributionsandmaintenanceenergyofeight6 Journal of Biomedicine and Biotechnology
Bacillus strains and discovered that B. licheniformis was
the most suitable for industrial biotechnology [96], (2)
they found that using malate as a substrate resulted in a
suppressed respiratory TCA cycle and an enhanced overﬂow
metabolism [97], and (3) they found the pentose precursors
of riboﬂavin were mainly synthesized via the nonoxida-
tive pentose-phosphate pathway, so any suggested genetic
modiﬁcation should decrease the activity of the oxidative
pentose-phosphate pathway [98]. Recently, they developed
a 13C-dMFA model for B. subtilis to identify the metabolic
response of riboﬂavin overproduction under a glucose-
limited fed-batch culture [40]. This dynamic ﬂux analysis
was obtained by recording changes in labeling patterns of
intracellular amino acids under a metabolic pseudosteady
state assumption.
4.3. Saccharomyces cerevisiae Model. S. cerevisiae is a robust
eukaryotic chassis used for the expression of a wide range
of products. For example, ﬂux analysis revealed target
genes in two native pathways for the overexpression of
succinate: the TCA and glyoxylate cycles [99]. Another study
showed the enhancement of sesquiterpene production via in
silico driven metabolic engineering [100]. Additionally, ﬂux
analysis has been extensively applied for improving ethanol
production. First, a number of strategies were developed
for the metabolic engineering of redox processes in S.
cerevisiae, resulting in a decrease in the yield of glycerol
by 40% and an increase in ethanol production under both
glucose and xylose/glucose growth conditions [101]. Second,
Dikicioglu et al. [102] applied a genome-scale FBA model
to analyze respiration-deﬁcient mutants of S. cerevisiae
for ethanol production. They found that many genetic
manipulation strategies (e.g., the overexpression of the
glutamate synthase gene) were unnecessary in a respiration-
deﬁcient metabolic background. This indicates that the rate
limiting steps for ethanol production can change after the
initial genetic manipulations of targeted genes. Third, a 13C-
MFA model was used to screen ethanol production in 14
hemiascomycetous yeast strains [51]. This study suggests
that S. cerevisiae is the ideal ethanol production candidate
due to a strong NADPH-driven pentose-phosphate pathway.
Other 13C-MFA studies characterized the metabolic shift
between oxidative growth and fermentative growth with
ethanol production [103], investigated alternative carbon
substrate (xylose) metabolisms [104], revealed key factors
inﬂuencing biomass growth on xylose [32], and examined
the consumption of ethanol and other storage carbohydrates
in a glucose-limited chemostat culture [105].
Furthermore, a genome-scale FBA indicates an apparent
enzyme dispensability, that is, 80% of yeast genes seem to
be nonessential for viability under laboratory conditions
[106].TheFBAillustratedtheinﬂuenceofnonessentialgenes
on metabolic robustness and environmental ﬁtness due to
genetic buﬀering through alternative genes, while a 13C-
MFA (consisting of over 700 reactions) revealed a similar
eﬀect of metabolic network robustness on null mutations
[47]. Understanding the role of these redundant genes is
important for a valid and eﬃcient genetic modiﬁcation.
4.4. Nonmodel Microorganisms. Fluxomics is an impor-
tant tool for the rigorous study of metabolism in less-
characterized microbes that provides novel insights for
application of these species to biotechnology. However,
ﬂuxomics have not been suﬃciently applied to nonmodel
microorganisms as compared to model microbial hosts.
Table 1 summarizes some milestone papers in ﬂuxomics
studies on nonmodel species that are potentially useful
for synthetic biology. Compared to the work done in
the ﬁeld of ﬂuxomics for industrial workhorses, far fewer
studies have been performed on nonmodel microorganisms.
This is due to the complicated growth conditions, poorly-
understood metabolic networks, and signiﬁcant lack of
genetic and molecular biology tools. However, nonmodel
environmentalmicroorganismsarealsoimportantforindus-
trial biotechnology because they often possess native bio-
chemical pathways for chemical synthesis or the ability to
utilize cheap substrates [120]. Furthermore, ﬂux analysis can
be used to discover novel enzymes that can be cloned into
industrial microbes to improve their capacity for product
synthesis. For example, 13C-MFA revealed a citramalate
pathway for isoleucine biosynthesis (independent of the
common threonine ammonia-lyase pathway) [121, 122].
Citramalate synthase, which has also been detected in some
environmental bacteria [123–125], can be engineered into
E. coli for 1-propanol and 1-butanol production. The new
pathway bypasses threonine biosynthesis and represents the
shortest keto-acid-mediated pathway; as such, it improved
biofuel yield 9 to 22-fold [126]. Currently, high-throughput
genome sequencing methods are mapping genomes in
novel microbes at a pace that far exceeds the pace of
functionalcharacterizationofthesespecies.Therefore,ahigh
throughput 13C-MFA technique is required for screening
nonmodel microorganisms for new enzymes and maximiz-
ing their application in industrial biotechnology [4].
5. Finding Bottlenecks for
IndustrialBiotechnology
Oneofthemaingoalsofﬂuxomicsistoindentifybottlenecks
forindustrialbiotechnologyandtherebyassistinthecreation
of rational engineering strategies. Simple measurements of
metabolism, however, are not enough to overcome unpre-
dictable challenges in industrial biotechnology. Metabolic
regulation is very complex, and systems biology tools are
incapable of revealing a general strategy for synthetic biology
[127].
Bottlenecks in industrial biotechnology can be explained
from the view of ﬂuxomics. First, metabolic robustness (the
ability to maintain metabolic performance under genetic
or environmental perturbations) is a long-recognized key
propertyofmicrobialsystems[128].Thisbasicmechanismis
often responsible for the gap between computationally aided
design and ﬁnal experimental outcomes. For example, a 13C-
MFAstudyindicatesthatE.colishowsremarkablerobustness
in the central carbon metabolism in the presence of genetic
variation, and is even more ﬂexible in response to alteredJournal of Biomedicine and Biotechnology 7
Table 1: Recent application of ﬂuxomics of nonmodel microbes to bioproduct synthesis.
Species Product Substrate Model description Results from study Reference
Corynebacterium
glutamicum Lysine Glucose (sucrose,
fructose)
13C-MFA
MFA models (combining transcriptome,
metabolome analysis) have been developed
to study ﬂuxes under diﬀerent cultivation
modes (minibioreactor, batch, fed-batch)
using various carbon sources.
[107]
Corynebacterium
glutamicum Methionine Glucose
13C-MFA only focuses
on ﬂux distribution in
the methionine pathway.
The C. glutamicum mutant (mcbR) showed
no overproduction of methionine, but
accumulation of homolanthionine.
[108]
Corynebacterium
glutamicum Glutamate Glucose
13C-MFA (focus on
anaplerotic pathways)
The ﬂux from phosphoenolpyruvate to
oxaloacetate catalyzed by
phosphoenolpyruvate carboxylase (PEPc)
was active in the growth phase, whereas
pyruvate carboxylase was inactive.
[109]
Actinobacillus
succinogenes
Succinate
formate and
acetate
Glucose NaHCO3
13C-MFA (via NMR and
GC-MS) and enzyme
assay
The model indicated (1) NADPH was
produced primarily by transhydrogenase
and/or by NADP-dependent malic enzyme
(2) oxaloacetate and malate were converted
to pyruvate (3) the eﬀects of NaHCO3 and
H2 on metabolic ﬂuxes were quantiﬁed.
[110,
111]
Geobacillus ther-
moglucosidasius Ethanol Glucose FBA and 13C-MFA
The model characterized the ethanol
production under three oxygen conditions.
The FBA analysis pointed out several gene
targets for improving ethanol production.
[19]
Clostridium
acetobutylicum Butanol Glucose Genome-scale-FBA
The engineered strain was able to produce
154 mM butanol with 9.9 mM acetone at
pH 5.5, resulting in a butanol selectivity (a
molar ratio of butanol to total solvents) of
0.84.
[112]
Penicillium
chrysogenum Penicillin Gluconate/glucose
13C- M F A( f o c u so n
pentose phose phase
pathway and glycolysis)
The model determined the
pentose-phosphate pathway split ratio and
estimated NADPH metabolism.
[113]
Synechocystis sp.
PCC6803 Hydrogen CO2 FBA
The results included H2 photoproduction,
strategies to avoid oxygen inhibition, and
analysis of hetero-, auto-, and mixotrophic
metabolisms.
[114,
115]
Synechocystis sp.
PCC6803
Light energy
&B i o m a s s Glucose/CO2
13C-MFA and dynamic
13C- M F A
The model analyzed heterotrophic,
autotrophic and mixotrophic metabolisms. [34, 58]
Chlamydomonas
reinhardtii
Light energy
&B i o m a s s CO2
FBA model including
three metabolically
active compartments
The model indicated that heterotrophic
growth had a low biomass yield on carbon,
while mixotrophical and autotrophical
growth had higher carbon utilization
eﬃciency.
[116]
Zymomonas
mobilis Ethanol Glucose/xylose FBA with various
biological objectives
Model analyzed the metabolic boundaries of
Z. mobilis. The study indicated that ethanol
and biomass production depend on
anaerobic respiration stoichiometry and
activity.
[117]
Zymomonas
mobilis Ethanol Glucose/fructose/
xylose
13C–MFA via 1H-NMR
31P-NMR spectroscopy
The model characterized the intracellular
metabolic state during growth on glucose,
fructose and xylose in deﬁned continuous
cultures.
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Table 1: Continued.
Species Product Substrate Model description Results from study Reference
Coculture
(Desulfovibrio
vulgaris and
Methanococcus
maripaludis)
CH4 Lactate FBA analysis of
microbial consortia
The model predicted the ratio of D. vulgaris
to M. maripaludis cells during growth. It
was possible to eliminate formate as an
interspecies electron shuttle, but H2 transfer
was essential for syntrophic growth.
[55]
Community
(oxygenic
phototrophs,
ﬁlamentous
anoxygenic
phototrophs, and
sulfate-reducing
bacteria).
Biomass
and
nitrogen
ﬁxation
CO2
FBA and elementary
mode analysis
The model predicted and described relative
abundances of species, by-products, and the
metabolic interactions.
[54]
Phaﬃa
rhodozyma and
Haematococcus
pluvialis
Astaxanthin
Glucose with
(peptone & yeast
extract)
FBA analysis of mix
culture
The two major astaxanthin-producing
microorganisms exhibited elevated yields
(2.8-fold) under mixed culture conditions
compared to pure culture.
[119]
environmental conditions (e.g., diﬀerent nutrients or oxygen
levels) [90]. Analyses of E. coli components at multiple
“omics” levels also reveal unexpectedly small changes in
messenger RNA, proteins and metabolite levels for most
genetic disruptions. This is because E. coli actively regulates
enzyme levels to maintain a stable metabolic state in the
presenceofperturbations[57,78].Similarly,B.subtilisshows
rigidity and suboptimal performance for its ﬂux regulation
in over 137 genetic backgrounds [42]. Furthermore, gene
essentiality and pairwise genetic interactions have been
investigated in S. cerevisiae [106, 129]. It has been found that
ag e n e ’ sf u n c t i o ni sb u ﬀered by duplication in S. cerevisiae
genomic DNA or by an alternative biochemical pathway.
Althoughonly 13% of genes weresuggestedto be essential by
single knockout experiments, simultaneous deletion of pairs
of nonessential genes (>70% of the total metabolic genes)
were found to inhibit growth. Invariability of metabolic ﬂux
undermutagenicgenotypesseemstobeanimportantfeature
in many biological systems, and thus successful metabolic
strategies highly depend on an understanding of robust
cellular nature [130–132].
Metabolic engineering of industrial chassis is based on
the premise that the yield of a desired product can be
increasedbyidentifying andoverexpressingtheenzymesthat
catalyze the rate-limiting steps in a given metabolic pathway.
However, a method based on overexpressing rate-limiting
enzymes will only work if these rate-limiting enzymes
exist and remain rate-limiting when their activities are
increased. Previous studies have shown that the commonly-
believed “rate-limiting” enzymes may not exist in some
industrial microbes and an increase in productivity has to be
achieved by coordinated expression of entire pathways [133].
Furthermore, rate-limiting steps in a metabolic network
often shift after initial targets have been engineered. For
example, phenotypic data in S. cerevisiae mutants revealed
thatsomeFBA-predictedgenetargetsforethanolproduction
are invalid if the cell’s respiratory genes have been knocked-
out [102]. Another example of this phenomenon is high-
lighted by the metabolic consequences of the deletion of
the methionine and cysteine biosynthesis repressor protein
(McbR) in Corynebacterium glutamicum, which yielded no
overproduction of methionine but drastic accumulation
of homolanthionine [108]. The above evidence indicates
that rate-limiting steps often shift after initial targets have
been engineered. Additionally, simultaneous importation
and expression of a few heterologous genes to improve the
rate-limiting pathway may fail if the nonnative pathway
is incompatible with the host. These eﬀorts often lead to
metabolic imbalance and accumulation of toxic metabolites
[2, 3].
Based on the recent publications, we have constructed
a linear regression model which shows that the yield of
biosynthetic products decreases exponentially as a function
of the steps away from central metabolism in S. cerevisiae
(Figure 3). It is easier to achieve high carbon ﬂuxes to
the central metabolites, possibly because enzyme eﬃciency
in central metabolism is usually high [134]. However, the
yields of secondary metabolites are smaller because each
additional enzymatic step may not be perfectly eﬃcient
(model regression shows an average of ∼67% eﬃciency in
each enzymatic step in secondary metabolisms). This loss of
yield is unavoidable due to the metabolism channeling the
intermediates away from the desired product. Potential solu-
tions to this problem include (1) designing host-compatible
enzymes with high product speciﬁcity [135], (2) feeding
intermediates to the cell to reduce the number of enzymatic
s t e p st oﬁ n a lp r o d u c t[ 136], and (3) creating synthetic
protein scaﬀolds, which signiﬁcantly improve intermediate
conversion eﬃciency and overall biosynthetic yield [137].
In conclusion, ﬂuxomics studies enable the quantiﬁca-
tion of intracellular metabolism. However, this tool is not
fully developed, and it remains diﬃcult to deduce cell-
wide pathway bottlenecks and to provide eﬀective strategiesJournal of Biomedicine and Biotechnology 9
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Figure 3: Product yields as a function of enzymatic steps from
central metabolism. The solid line is the regression of published
product yields by S. cerevisiae as a function of reaction steps
from intermediate metabolites in central metabolism (including
glycolysis, TCA cycle and pentose-phosphate pathways). The yield
declines exponentially as the number of reaction steps increases.
The dotted lines are boundary curves with yield eﬃciencies of 30%
and 70% respectively. All yield data from initial carbon sources are
estimated from recent papers using our best judgment. The synthe-
sized products and reaction steps are: Poly(R-3-hydroxybutyrate)
[63](steps=3);Glycerol[64](steps=2);Artemisinicacid[1](steps
= 10); Amorphadiene [65]( s t e p s= 9); Pyruvate [66]( s t e p s= 0);
Geranylgeraniol[67](st eps=10);Hydrocortisone[68](st eps=19);
Squalene [69]( s t e p s= 9); β-carotene [70]( s t e p s= 12); Lycopene
[70]( s t e p s= 11); Phytoene [70]( s t e p s= 10); p-hydroxycinnamic
acid [71]( s t e p s= 12); Naringenin [72]( s t e p s= 14); Pinocembrin
[72]( s t e p s= 14); Xylitol and Ribitol [73]( s t e p s= 3); Ethanol [74]
(steps = 2); L-ascorbic acid [75]( s t e p s= 8).
for biotechnology applications. Numerous technical diﬃcul-
ties in developing ﬂux analysis methods and complicated
metabolic regulatory mechanisms have severely limited the
scopeofﬂuxomicsinindustrialbiotechnology.Itisnecessary
for the future development of ﬂux analysis to combine other
advanced “omics” analysis and molecular biology techniques
to resolve challenges in the ﬂuxomics ﬁelds.
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